The burden of emerging antimicrobial resistance (AMR) in the United States is significant
and even greater worldwide. Mitigation efforts have decreased the incidence and deaths …

Lung transplantation connects two microbiotas: one derived from the donor's lower
respiratory tract with one from the recipient's upper respiratory tract. Similarly, liver …

Background Solid organ transplant (SOT) recipients are at risk of bloodstream infections
(BSIs) with MDR organisms (MDROs). Objectives To describe the epidemiology of BSI in the …

Background Recurrent urinary tract infections (rUTIs) are common after renal transplantation
(RTx), and the impact on graft and patient survival remains controversial. Objective In this …

Background Experience of ceftazidime-avibactam (CAZ/AVI) for carbapenem-resistant
Pseudomonas aeruginosa (CRPA) infection in recipients after lung transplantation (LT) is …

Solid organ transplant (SOT) recipients are particularly susceptible to infections caused by
multidrug-resistant organisms (MDRO) and are often the first to be affected by an emerging …

Background: Solid organ transplant (SOT) recipients are at risk of severe COVID-19.
Vaccination is an important preventive measure but may have side effects, including …

Purpose The Management of Post-transplant Infections in Collaborating Hospitals (MATCH)
programme, initiated in 2011 and still ongoing, was created to 1) optimise the …

The aging population of KTX recipients requires a personalized approach to effectively
reduce and manage UTIs as one of the most important complications following KTX …

Bone and joint infection (BJI) epidemiology and outcomes in solid organ transplant
recipients (SOTr) remain largely unknown. We aim to describe BJI in a multi-center cohort of …